Artificial intelligence could help us to assess scans of patients with bone disease, thanks to an innovative software toolkit developed at the BRC.

The 'Man Van', an innovative new outreach programme, has been launched today (Friday 18 March) to provide free health checks for men and boost early diagnosis of prostate and other urological cancers. 

Experts at The Royal Marsden and The Institute of Cancer Research, with support from the NIHR BRC at The Royal Marsden and ICR, are leading on pioneering cancer research, with their work being published in high-profile journals.

A new incubator and collaboration space for innovative life-science companies whose work is relevant to cancer is opening its doors at The London Cancer Hub in Sutton, south London.

NHS guidelines for gene testing miss half of people carrying inherited genetic changes linked to cancer, a new study reports.

Professor Chris Nutting, a Consultant Clinical Oncologist at The Royal Marsden and Professor of Radiotherapy at The Institute of Cancer Research, London, has been appointed as a National Institute for Health Research (NIHR) Senior Investigator.

The Royal Marsden NHS Foundation Trust has received a £3.1m funding boost as a National Institute for Health Research (NIHR) Clinical Research Facility (CRF) to help support our early-stage clinical research.

The Royal Marsden NHS Foundation Trust has been awarded two SBRI Healthcare funding awards for late-stage innovation projects that advance the earlier and faster detection of cancer.

Researchers at The Royal Marsden NHS Foundation Trust, the Francis Crick Institute and University College London have found immune cell patterns in tumours that can help predict whether patients with kidney cancer will respond to immunotherapy. 

A local breast cancer prevention project is aiming to inform and empower women to make lifestyle changes to reduce their risk of developing the disease.